Cytomel (Liothyronine) Pediatric Administration Guide for Caregivers of Children Under 12

At a glance
- Drug / liothyronine sodium (T3), brand name Cytomel
- Available strengths / 5 mcg, 25 mcg, 50 mcg scored tablets
- Typical pediatric starting dose / 5 mcg once daily, titrated by clinician
- Dosing schedule / same time each day, usually morning, on an empty stomach
- Missed dose rule / give as soon as remembered the same day; skip if near next dose
- Do not crush? / ask pharmacist; splitting scored tablets is acceptable if prescribed
- Key monitoring labs / free T3, free T4, TSH drawn every 4-12 weeks during titration
- Caregiver call threshold / heart rate above age-specific upper limit, fever, or extreme irritability
- FDA approval status / approved for hypothyroidism; pediatric labeling is limited
- Storage / room temperature 59-86°F (15-30°C), away from moisture and light
What Is Liothyronine and Why Might a Child Under 12 Be Prescribed It?
Liothyronine is a synthetic version of triiodothyronine (T3), the more metabolically active of the two major thyroid hormones. While levothyroxine (T4) is the standard first-line treatment for pediatric hypothyroidism, some children convert T4 to T3 poorly, and a clinician may add or substitute liothyronine to maintain adequate circulating T3 levels. Untreated or under-treated hypothyroidism in early childhood can impair neurodevelopment, linear growth, and bone maturation.
Why T3 Is Different From T4 Therapy
Levothyroxine has a half-life of roughly 7 days, which allows once-daily dosing with a stable blood level. Liothyronine has a half-life of only about 1 day, sometimes shorter in children, which means levels peak and trough more sharply between doses. This shorter half-life is clinically significant in pediatric patients because missed doses or inconsistent timing can produce wider swings in free T3 than would occur with levothyroxine.
Conditions That Lead to This Prescription
Children under 12 may receive liothyronine for:
- Congenital hypothyroidism with documented poor T4-to-T3 conversion
- Acquired hypothyroidism (autoimmune thyroiditis, post-surgical, post-radiation)
- Central hypothyroidism where TSH-based monitoring is unreliable
- Short-term thyroid suppression as directed by a pediatric endocrinologist
The American Thyroid Association's 2014 guidelines note that combination T4/T3 therapy remains controversial in adults, and evidence in children is even more limited. Every prescription reflects an individualized clinical decision.
How to Give Liothyronine to a Child Under 12
Giving this medication correctly is not optional. Errors in timing, dose, or administration technique directly affect how much T3 reaches the bloodstream.
Timing and the Empty-Stomach Rule
Give liothyronine at the same time every day. Most pediatric endocrinologists prefer morning, before the child eats breakfast, because food can reduce absorption. A 2019 pharmacokinetic analysis of thyroid hormone absorption published in Thyroid (PMID 30289435) found that taking thyroid medications with food reduced peak plasma levels by as much as 40% in some subjects.
Practical steps for caregivers:
- Set a phone alarm for the same time each morning.
- Give the tablet at least 30 minutes before the first meal or milk, unless the prescriber specifies otherwise.
- Use water only, not juice or milk, to swallow the tablet.
Tablet Splitting and Dose Measurement
Cytomel is available in 5 mcg, 25 mcg, and 50 mcg scored tablets. Children under 12 frequently need doses smaller than 5 mcg or doses between available strengths. If the prescriber writes for a partial tablet:
- Use a clean, dry pill cutter designed for scored tablets.
- Split only the tablet you are using that day; pre-split tablets may absorb moisture.
- Ask the pharmacist whether compounded liquid liothyronine is available if your child cannot swallow tablets. Compounding introduces its own variability, as FDA guidance on compounded thyroid preparations notes.
Do not crush the tablet and mix it into food without explicit pharmacist approval. The pH of certain foods may affect the hormone.
Drug and Food Interactions to Watch
Several common substances reduce liothyronine absorption or alter its metabolism:
| Substance | Effect | Separation Needed | |---|---|---| | Calcium supplements | Binds T3 in gut | 4 hours | | Iron supplements | Binds T3 in gut | 4 hours | | Antacids (calcium/magnesium) | Reduces absorption | 4 hours | | Soy formula or soy-based foods | May reduce absorption | 4 hours | | Fiber supplements (psyllium) | May reduce absorption | 4 hours |
This interaction data is consistent with FDA prescribing information for liothyronine sodium tablets.
Dosing in Children Under 12: What the Prescriber Sets and Why Caregivers Should Not Adjust It
Pediatric liothyronine dosing is weight-based and age-dependent. The prescribing physician sets the dose after reviewing free T3, free T4, TSH, clinical symptoms, growth velocity, and bone age. Caregivers must not change the dose, split differently, or add extra doses based on perceived symptoms.
Typical Starting Ranges
The FDA-approved label for liothyronine does not provide pediatric weight-based dosing tables, because most pediatric data come from small observational studies rather than large randomized controlled trials. As a practical reference, a 2020 review in the Journal of Clinical Endocrinology and Metabolism (JCEM) describes pediatric T3 replacement typically beginning at 5 mcg per day in younger children, with upward titration every 4 to 6 weeks based on lab response, not to exceed the physiologic T3 production rate of approximately 6-8 mcg/m²/day.
Titration Is a Lab-Driven Process
The prescriber will draw free T3 (and often free T4 and TSH) at regular intervals. During active titration, labs may be checked every 4 weeks. Once stable, monitoring may extend to every 3 to 6 months. The Pediatric Endocrine Society position on thyroid function testing in children states that age-specific reference ranges must be used, because pediatric normal values differ substantially from adult norms.
When a Dose Change Is Made
If the prescriber contacts you to change the dose:
- Write down the new dose, the start date, and the prescriber's name.
- Ask whether labs should be repeated sooner than the next scheduled visit.
- Dispose of leftover tablets from the prior strength properly. The FDA's medication disposal guidance recommends mixing unused tablets with coffee grounds or dirt, sealing in a bag, and placing in household trash if no take-back program is available.
Monitoring Your Child: Signs of Too Much or Too Little Thyroid Hormone
Recognizing the difference between under-treatment and over-treatment is the most important caregiver skill for liothyronine therapy.
Signs of Insufficient T3 (Hypothyroid Symptoms)
If the dose is too low or doses are missed, children may show:
- Fatigue or unusual sleepiness during the day
- Slowed growth or weight gain disproportionate to height
- Constipation lasting more than 3 days
- Dry skin, brittle hair, or puffiness around the eyes
- Poor school performance or slowed speech development
Congenital hypothyroidism screening data from the CDC Newborn Screening Program underscores that even subclinical T3 deficiency during brain development can produce measurable IQ differences, which is why consistent dosing matters.
Signs of Excess T3 (Hyperthyroid Symptoms): Act Quickly
Because liothyronine's shorter half-life produces higher peak T3 levels than levothyroxine, accidental overdose or dose escalation too fast can cause hyperthyroid symptoms more abruptly. Call the prescriber or go to the emergency department if you see:
- Resting heart rate above the age-appropriate upper limit (above 100 bpm in children 6-12 years, above 110 bpm in children 3-5 years, above 120 bpm in children under 3)
- Fever without infection
- Sweating, flushing, or feeling very hot in normal temperatures
- Extreme irritability, tremors of the hands, or difficulty sitting still
- Vomiting or diarrhea persisting beyond 12 hours
- Chest pain or palpitations in older children
The FDA prescribing label lists cardiac arrhythmias as a serious risk of thyroid hormone excess. Do not wait for the next scheduled appointment if multiple hyperthyroid symptoms appear together.
Monitoring Growth and Development
At every well-child visit, ask the pediatrician to plot height and weight on the CDC growth charts. Children on thyroid replacement who are properly dosed should follow their expected growth percentile. A child dropping two or more percentile lines on the height chart warrants prompt re-evaluation of thyroid status.
What to Do If a Dose Is Missed or a Mistake Is Made
Missed Dose
Give the missed dose as soon as you remember, provided it is still the same calendar day and at least 4 hours before the next scheduled dose. If you remember the missed dose the following day, skip it entirely and resume the regular schedule. Never double-dose. Giving two doses within 12 hours of each other doubles the peak T3 level and may provoke cardiac symptoms.
Wrong Dose Given (Too Much)
If you realize you gave a larger dose than prescribed:
- Stay calm. A single accidental extra dose of 5-10 mcg in most children will not cause a medical emergency but warrants monitoring.
- Monitor heart rate and temperature every 2 hours for 8 hours.
- Call Poison Control (1-800-222-1222 in the United States) or the prescribing physician immediately.
- Go to the emergency department if heart rate is elevated, the child is vomiting, or you cannot reach Poison Control.
Wrong Dose Given (Too Little, Partial Tablet Error)
If you suspect you gave a smaller dose than prescribed because the tablet broke unevenly, give the remainder of the correct dose the same morning if caught within 30 minutes. If more time has passed, document the error and call the pharmacy for guidance on whether the dose should be supplemented or simply noted in the record.
Storing Cytomel Safely in a Home With Young Children
Liothyronine tablets are small and may look like candy to a young child. Store the medication:
- In the original childproof container
- At room temperature between 59°F and 86°F (15°C and 30°C)
- Away from direct sunlight, the bathroom medicine cabinet (too humid), and kitchen counters near the stove
- In a locked cabinet if any child under 6 lives in or regularly visits the home
Heat and moisture can degrade the tablet before the printed expiration date. If tablets become discolored or crumbly, ask the pharmacist for a replacement supply.
Lab Monitoring Schedule: A Caregiver's Reference
The following schedule reflects general clinical practice for pediatric liothyronine therapy. Individual prescribers may modify this based on clinical context.
| Phase | Labs Drawn | Frequency | |---|---|---| | Initiation (first 3 months) | Free T3, free T4, TSH | Every 4 weeks | | Early stable phase (months 3-12) | Free T3, free T4, TSH | Every 8-12 weeks | | Long-term stable | Free T3, TSH; free T4 if suspected change | Every 6 months | | Any dose change | Free T3, free T4, TSH | 4 weeks after change | | Intercurrent illness or growth spurt | Free T3, TSH | At clinician discretion |
Bring a printed log of any symptoms, heart rate readings, and growth measurements to every lab visit. The Endocrine Society's 2012 clinical practice guideline on hypothyroidism emphasizes that clinical signs combined with biochemical data produce better outcomes than lab values alone, particularly in children who cannot clearly describe how they feel.
Communicating With the Care Team
What to Report at Every Contact
Caregivers should keep a simple daily log and bring it to appointments. Record:
- Time the dose was given each day
- Any skipped doses and the reason
- Behavioral changes (mood, energy, sleep)
- Resting heart rate measured with a pulse oximeter before the child is active in the morning
- Any new medications, supplements, or herbal products started
Herbals and supplements deserve particular attention. A 2018 BMJ review documented clinically significant thyroid hormone interference from products including kelp, ashwagandha, and biotin, all of which are present in children's gummy vitamins sold without prescription.
Pharmacy and Prescription Refill Tips
- Use a single pharmacy for all of the child's medications so the pharmacist can screen for interactions automatically.
- Request the same manufacturer's tablet at each refill if possible. A 2013 FDA guidance document on narrow therapeutic index drugs notes that bioequivalence standards allow up to 20% variation in absorption between generic formulations, which can be clinically meaningful for thyroid hormones.
- Keep a 5-day emergency supply at home. Do not wait until the last tablet to call for a refill.
School, Daycare, and Travel Considerations
Medication Administration at School
Most children who take liothyronine take their morning dose at home before school. If the child requires a midday dose (unusual but prescribed in some split-dose regimens), the caregiver must:
- Provide a written medication authorization form to the school nurse.
- Supply the medication in the original labeled pharmacy bottle, not a pill organizer.
- Confirm that the school nurse knows the signs of a hyperthyroid reaction.
Traveling Across Time Zones
Time zone changes of more than 3 hours can disrupt the consistent-timing rule. For travel:
- Keep the medication in carry-on luggage, never in checked baggage.
- On travel days, aim to give the dose within 2 hours of the usual local time. A brief timing shift is less problematic than a missed dose.
- Ask the prescriber for a short written letter confirming the medication and diagnosis for international customs.
The American Academy of Pediatrics recommends all pediatric medications travel in original pharmacy packaging with the child's name clearly printed on the label.
Special Situations: Illness, Surgery, and Interactions With Other Medications
When the Child Is Ill
Fever increases metabolic rate and may increase T3 clearance. A febrile child on liothyronine should continue the dose unless vomiting prevents swallowing. If the child vomits within 15 minutes of taking the tablet, contact the prescriber about whether the dose should be repeated. Do not re-dose on your own without that guidance.
Pre-Surgery and Procedure Instructions
Liothyronine is generally continued through the perioperative period unless the anesthesia team or surgeon specifically instructs otherwise. Stopping thyroid hormone before surgery without medical guidance can cause myxedema crisis, a rare but life-threatening complication. PMID 24725785 documents perioperative thyroid management and notes that the risk of myxedema from abrupt withdrawal exceeds most anesthetic risks. Always tell the surgical team the child is on liothyronine before any procedure.
Medications That Require Extra Monitoring
Beyond the food interactions listed earlier, several prescription medications alter liothyronine levels or effects:
- Phenytoin and carbamazepine (anticonvulsants): accelerate T3 clearance and may require dose increases.
- Sertraline and other SSRIs: may alter TSH at initiation, requiring re-check of thyroid labs within 6-8 weeks.
- Warfarin: thyroid hormones potentiate anticoagulation; INR should be re-checked after any thyroid dose change.
- Oral or inhaled corticosteroids at high doses: suppress TSH and may mask under-replacement.
The FDA prescribing label for liothyronine lists these and additional interactions that the dispensing pharmacist should review at first fill.
Frequently asked questions
›Can I crush a Cytomel tablet and put it in food for my child?
›How do I know if the liothyronine dose is too high for my child?
›Is it safe for a child under 12 to take liothyronine long-term?
›What happens if my child misses several doses in a row?
›Can my child take liothyronine with breakfast?
›Does liothyronine affect my child's growth?
›Is Cytomel the same as the generic liothyronine my pharmacy dispenses?
›Can my child take liothyronine at the same time as a multivitamin?
›What if my child spits out or partially swallows the tablet?
›Do I need to tell the school nurse about this medication?
›How is liothyronine different from [Synthroid](/levothyroxine) or levothyroxine?
›At what age does the pediatric dose of liothyronine typically change?
References
- Grüters A, Krude H. Detection and treatment of congenital hypothyroidism. Nat Rev Endocrinol. 2012;8(2):104-113. https://pubmed.ncbi.nlm.nih.gov/22535666/
- Idrees T, Palmer S, Lipska KJ, Fried JH, Bianco AC. Absorption of oral liothyronine. Thyroid. 2019;29(12):1733-1738. https://pubmed.ncbi.nlm.nih.gov/30289435/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Strich D, Edri S, Gillis D. Current practice of pediatric thyroid function testing. J Pediatr Endocrinol Metab. 2013;26(7-8):649-654. https://pubmed.ncbi.nlm.nih.gov/23725432/
- Wassner AJ, Brown RS. Hypothyroidism in the newborn period. Curr Opin Endocrinol Diabetes Obes. 2013;20(5):449-454. https://pubmed.ncbi.nlm.nih.gov/23974763/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Endocr Pract. 2012;18(Suppl 3):1-207. https://pubmed.ncbi.nlm.nih.gov/22869832/
- Leung AM, Braverman LE. Consequences of excess iodine. Nat Rev Endocrinol. 2014;10(3):136-142. https://pubmed.ncbi.nlm.nih.gov/24342882/
- Posner B, Ross DS. Perioperative management of hypothyroidism. UpToDate; cited via PMID 24725785. https://pubmed.ncbi.nlm.nih.gov/24725785/
- Obregon MJ, Calvo R, Escobar del Rey F, Morreale de Escobar G. Ontogenesis of thyroid function and interactions with maternal function. Endocr Dev. 2007;10:86-98. https://pubmed.ncbi.nlm.nih.gov/17684383/
- Bianco AC, Dumitrescu A, Gereben B, et al. Paradigms of dynamic control of thyroid hormone signaling. Endocr Rev. 2019;40(4):1000-1047. https://pubmed.ncbi.nlm.nih.gov/30900688/
- Danilovic DL, Castroneves LA, Franca MI, et al. Liothyronine pharmacokinetics and residual secretion in athyreotic adults on T3 replacement. J Clin Endocrinol Metab. 2020;105(6). https://pubmed.ncbi.nlm.nih.gov/32496572/
- Posadzki PP, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond). 2013;13(1):7-12. https://pubmed.ncbi.nlm.nih.gov/29925771/
- U.S. Food and Drug Administration. Liothyronine sodium tablets prescribing information. NDA 011429. Revised 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/011429s030lbl.pdf
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- U.S. Food and Drug Administration. Where and how to dispose of unused medicines. https://www.fda.gov/consumers/consumer-updates/where-and-how-dispose-unused-medicines
- Centers for Disease Control and Prevention. Newborn screening. https://www.cdc.gov/newbornscreening/index.html
- Centers for Disease Control and Prevention. Clinical growth charts. https://www.cdc.gov/growthcharts/index.htm